// App-Quantinova.ai

3851 : Synergy between statins and BCL-2 inhibitors in blood cancers

Researchers

Presenter

  • Jong-Hoon S. Lee

Principal Investigators

  • Thanh-Trang T. Vo

  • David A. Fruman

Medical Centers

  • University of California, Irvine, Fullerton, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

  • Chronic Lymphocytic Leukemia

  • Hematological malignancies

  • Acute myelocytic leukemia

  • B cell lymphomas

  • Lymphomas

  • Solid malignancies

Biomarkers

  • cMYC

  • Gamma glutamyltransferase

Drug/Treatment

  • Simvastatin

  • Venetoclax

Outcome

  • N/A


Study Design

  • Pharmacodynamics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A